Smoking and myocardial infarction: secondary prevention.
نویسندگان
چکیده
منابع مشابه
Smoking and myocardial infarction: secondary prevention.
This prospective study examines the question 'Is it too late to stop smoking cigarettes once you have had a myocardial infarction?' One hundred and nineteen cigarette smokers (90 men, 29 women) who survived their first myocardial infarction for one month were followed for five years or until their death if earlier. The age corrected mortality rate of men who continued to smoke cigarettes was 2....
متن کاملSecondary Prevention after Myocardial Infarction
Myocardial infarction reflects the most severe form of ischaemic heart disease (IHD) and falls under the increasingly used umbrella term, acute coronary syndrome (ACS). Improvements in the acute management of myocardial infarction have seen deaths due to the condition fall by 31% over the period from 2002 to 2011. Nonetheless, behind this encouraging headline lie some less positive statistics. ...
متن کامل[Secondary prevention after a myocardial infarction].
Patients after a myocardial infarction are at increased risk of adverse cardiovascular outcomes. They require aggressive secondary preventive measures to control cardiovascular risk factors, and prescription of some pharmacological agents. Compelling data derived from randomized controlled trials have shown the benefits of aspirin (or clopidogrel), statins, beta-blockers and angiotensin-convert...
متن کاملSecondary prevention: improving outcomes following myocardial infarction.
In the first five years of the 1990s, the role of angiotensin converting enzyme (ACE) inhibitors in the treatment of patients with myocardial infarction was investigated in a series of large controlled trials involving more than 100 000 patients (table 1). The early use of ACE inhibitors after acute myocardial infarction (MI) has been investigated in four trials (CONSENSUS II, GISSI 3, ISIS 4, ...
متن کاملBeta-blocker therapy for secondary prevention of myocardial infarction.
Beta-blockers are effective agents for secondary prevention post-myocardial infarction (MI). They have antiarrhythmic, anti-ischemic, and antihypertensive effects that decrease morbidity and mortality in patients after an MI. Critical care nurses can play an active role in recognizing those patients, especially high-risk individuals, who may benefit from beta-blocker therapy.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Postgraduate Medical Journal
سال: 1985
ISSN: 0032-5473
DOI: 10.1136/pgmj.61.714.295